$13.5 Billion is the total value of ALPS ADVISORS INC's 892 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FLJP | New | FRANKLIN JAPANetf | $11,796,000 | – | 491,070 | +100.0% | 0.09% | – |
| ACAD | New | ACADIA PHARMACEU | $8,039,000 | – | 300,750 | +100.0% | 0.06% | – |
| ALKS | New | ALKERMES PLC | $7,377,000 | – | 327,275 | +100.0% | 0.06% | – |
| ETRN | New | EQUITRANS MIDSTR | $6,318,000 | – | 320,526 | +100.0% | 0.05% | – |
| MOR | New | MORPHOSYS AG ADR | $6,407,000 | – | 265,420 | +100.0% | 0.05% | – |
| AKCA | New | AKCEA THERAPEUTI | $4,535,000 | – | 193,375 | +100.0% | 0.03% | – |
| ALLK | New | ALLAKOS INC | $3,894,000 | – | 89,860 | +100.0% | 0.03% | – |
| GOSS | New | GOSSAMER BIO INC | $3,059,000 | – | 137,925 | +100.0% | 0.02% | – |
| ORTX | New | ORCHARD THERAPEU | $2,778,000 | – | 198,550 | +100.0% | 0.02% | – |
| RARX | New | RA PHARMACEUTICA | $2,663,000 | – | 88,545 | +100.0% | 0.02% | – |
| EPZM | New | EPIZYME INC | $2,386,000 | – | 190,125 | +100.0% | 0.02% | – |
| EIDX | New | EIDOS THERAPEUTI | $2,395,000 | – | 77,075 | +100.0% | 0.02% | – |
| DRNA | New | DICERNA PHARMACE | $2,252,000 | – | 143,000 | +100.0% | 0.02% | – |
| DCPH | New | DECIPHERA PHARMA | $1,802,000 | – | 79,925 | +100.0% | 0.01% | – |
| PRNB | New | PRINCIPIA BIOPHA | $1,658,000 | – | 49,950 | +100.0% | 0.01% | – |
| YMAB | New | Y-MABS THERAPEUT | $1,637,000 | – | 71,575 | +100.0% | 0.01% | – |
| DD | New | DUPONT DE NEMOUR | $1,395,000 | – | 18,576 | +100.0% | 0.01% | – |
| ANIK | New | ANIKA THERAPEUTI | $1,208,000 | – | 29,735 | +100.0% | 0.01% | – |
| CRNX | New | CRINETICS PHARMA | $1,263,000 | – | 50,525 | +100.0% | 0.01% | – |
| MGTA | New | MAGENTA THERAPEU | $1,190,000 | – | 80,675 | +100.0% | 0.01% | – |
| PBYI | New | PUMA BIOTECHNOLO | $1,027,000 | – | 80,800 | +100.0% | 0.01% | – |
| RIGL | New | RIGEL PHARMACEUT | $913,000 | – | 349,950 | +100.0% | 0.01% | – |
| MRKR | New | MARKER THERAPEUT | $754,000 | – | 95,150 | +100.0% | 0.01% | – |
| PHAS | New | PHASEBIO PHARMAC | $771,000 | – | 58,775 | +100.0% | 0.01% | – |
| AGEN | New | AGENUS INC | $843,000 | – | 281,000 | +100.0% | 0.01% | – |
| SRRK | New | SCHOLAR ROCK HOL | $870,000 | – | 54,875 | +100.0% | 0.01% | – |
| CNST | New | CONSTELLATION PH | $663,000 | – | 54,000 | +100.0% | 0.01% | – |
| MDT | New | MEDTRONIC PLC | $690,000 | – | 7,089 | +100.0% | 0.01% | – |
| ASMB | New | ASSEMBLY BIOSCIE | $721,000 | – | 53,475 | +100.0% | 0.01% | – |
| PRQR | New | PROQR THERAPEUTI | $740,000 | – | 81,350 | +100.0% | 0.01% | – |
| DIS | New | WALT DISNEY CO | $687,000 | – | 4,918 | +100.0% | 0.01% | – |
| PEP | New | PEPSICO INC | $684,000 | – | 5,218 | +100.0% | 0.01% | – |
| KO | New | COCA-COLA CO/THE | $691,000 | – | 13,563 | +100.0% | 0.01% | – |
| DBI | New | DESIGNER BRANDS | $580,000 | – | 30,248 | +100.0% | 0.00% | – |
| CNR | New | CORNERSTONE BUIL | $604,000 | – | 103,539 | +100.0% | 0.00% | – |
| MNKD | New | MANNKIND CORP | $452,000 | – | 393,050 | +100.0% | 0.00% | – |
| NMFC | New | NEW MOUNTAIN FINANCE CORP | $258,000 | – | 18,500 | +100.0% | 0.00% | – |
| CUZ | New | COUSINS PROP | $271,000 | – | 7,500 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Red Rocks Capital LLC #1
- Morningstar Investment Management LLC #2
- Rocky Mountain Advisers, LLC #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENTERPRISE PRODUCTS PARTNERS L | 45 | Q2 2024 | 8.6% |
| PLAINS ALL AMER PIPELINE LP | 45 | Q2 2024 | 8.5% |
| Genesis Energy MLP | 45 | Q2 2024 | 2.7% |
| Vgrd Total Bond Mkt ETF | 45 | Q2 2024 | 1.4% |
| Vgrd MSCI EAFE ETF | 45 | Q2 2024 | 1.0% |
| PFIZER INC | 45 | Q2 2024 | 0.8% |
| VERIZON COMMUNICATIONS INC | 45 | Q2 2024 | 0.6% |
| Vgrd FTSE Emerge Mkt ETF | 45 | Q2 2024 | 0.5% |
| AT&T INC | 45 | Q2 2024 | 0.4% |
| ALTRIA GROUP INC | 45 | Q2 2024 | 0.4% |
View ALPS ADVISORS INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EnLink Midstream, LLC | February 05, 2024 | 41,475,283 | 9.1% |
| GENESIS ENERGY LP | February 05, 2024 | 18,776,684 | 15.3% |
| GLOBAL PARTNERS LP | February 05, 2024 | 4,431,751 | 13.0% |
| NuStar Energy L.P. | February 05, 2024 | 19,851,295 | 15.8% |
| PLAINS ALL AMERICAN PIPELINE LP | February 05, 2024 | 60,732,044 | 8.7% |
| SUBURBAN PROPANE PARTNERS LP | February 05, 2024 | 10,743,954 | 16.8% |
| Sunoco LP | February 05, 2024 | 9,498,706 | 9.4% |
| USA Compression Partners, LP | February 05, 2024 | 8,772,895 | 8.9% |
| Western Midstream Partners, LP | February 05, 2024 | 32,322,784 | 8.5% |
| Crestwood Equity Partners LP | February 13, 2023 | 12,335,027 | 11.8% |
View ALPS ADVISORS INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-26 |
| 13F-HR | 2024-08-13 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G | 2024-02-05 |
View ALPS ADVISORS INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.